The prophylactic treatment of hemophilia B Leyden with anabolic steroids.
D045930:Anabolic Agents / Q000627:therapeutic use*; D001846:Bone Development / Q000187:drug effects; D002648:Child; D005032:Ethylestrenol / Q000009:adverse effects / Q000627:therapeutic use; D005164:Factor IX / Q000378:metabolism; D002836:Hemophilia B / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D013739:Testosterone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D045930:Anabolic Agents; D013739:Testosterone; D005164:Factor IX; D005032:Ethylestrenol; C010792:testosterone undecanoate